ANALYSIS OF CHINESE MEDICINE MARKET
Natural Medicine Marketing Services, in conjunction with East-West Herbs, is to publish a report on the structure, potential market and joint venture opportunities in the traditional Chinese medicine market.
The report will detail the commercial, scientific and regulatory aspects of the Chinese market, including the main players in the industry, and provide an analysis of joint-venture opportunities for western pharmaceutical manufacturers with respect to product availability and research and development capabilities of the companies involved. The report will cost L2,500 ($3,750), with a discount to L1,750 for applications before June 30. For further information contact Sophie Kuipers, NMMS, 261 Portobello Rd, London. Phone: (071) 727 1753; fax (071) 379 1312.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze